 Comparative efficacies ciprofloxacin amoxicillin amoxicillin-clavulanic acid cefaclor experimental Streptococcus pneumoniae respiratory infections mice Experimental respiratory infections mice intranasal inoculation Streptococcus pneumoniae Inoculation CFU pneumoniae fatal pneumonia nontreated mice days infection Oral therapy infection times day days doses mice peak concentrations serum lung tissue similar humans Ciprofloxacin strain pneumococcus mouse lungs doses mg/kg body weight end therapy Mice ciprofloxacin mg/kg clear days whereas persistence regrowth pneumoniae death animals ciprofloxacin Therapy cefaclor mg/kg effect similar ciprofloxacin contrast amoxicillin mg/kg amoxicillin-clavulanic acid mg/kg effective strains pneumoniae lungs end therapy mortality treated animals efficacy ciprofloxacin experimental pneumococcal respiratory infections poor good penetration lung tissue reflection low vitro activity quinolone pneumoniae common pathogens community-acquired pneumonia